EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 1 filers reported holding EIDOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $41,766,000 | +160.4% | 317,417 | 0.0% | 0.64% | +103.8% |
| Q3 2020 | $16,039,000 | +58.0% | 317,417 | +49.0% | 0.31% | +42.1% |
| Q2 2020 | $10,154,000 | -2.7% | 213,000 | 0.0% | 0.22% | -34.6% |
| Q1 2020 | $10,435,000 | +216.7% | 213,000 | +31.5% | 0.34% | +146.7% |
| Q2 2018 | $3,295,000 | – | 162,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,123,630 | $64,485,000 | 24.71% |
| RA Capital Management | 2,162,671 | $124,116,000 | 3.76% |
| Opaleye Management Inc. | 315,550 | $18,109,000 | 3.55% |
| Parkman Healthcare Partners LLC | 207,271 | $11,895,000 | 3.43% |
| Board of Trustees of The Leland Stanford Junior University | 265,670 | $15,247,000 | 1.85% |
| Cormorant Asset Management, LP | 495,692 | $28,448,000 | 1.14% |
| Redmile Group, LLC | 701,178 | $40,241,000 | 0.96% |
| Ikarian Capital, LLC | 100,000 | $5,739,000 | 0.93% |
| Perceptive Advisors | 697,524 | $40,030,000 | 0.80% |
| EAM Global Investors LLC | 33,680 | $1,933,000 | 0.77% |